Long-Acting Injectables Curb Schizophrenia Readmission

Patients with schizophrenia discharged on an LAI antipsychotic had significantly lower 30-day psychiatric readmission rates than those sent home with an oral antipsychotic.
Medscape Medical News

source https://www.medscape.com/viewarticle/long-acting-injectable-antipsychotics-reduce-schizophrenia-2024a10002nf?src=rss

Comments

Popular posts from this blog

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

New AAFP practice guideline sets blood pressure targets for adults with hypertension